Skip to main content

RVTY Revvity, Inc.

Healthcare

151.65 -5.36 -3.41% Close 11/2
Since 2024-12-02 +35.3%
Open
160.07
High
160.07
Low
150.62
Prev close
157.00
Volume
2.8M
Amplitude
6.02%
P/E
75.3
P/B
2.4
Revenue YoY (TTM)
+3.7%
52W 81.22 169.06

Is Revvity, Inc. a buy? Fundamentals and valuation first

As of 2026-10-30

Quality: Good, Momentum: Strong, Risk / liquidity: Good; Valuation: Pricey.

Valuation Pricey Free-cash-flow yield is Good, but TTM P/E is Expensive.
TTM P/E 75.31 89th percentile Expensive
Price / book 2.42 65th percentile Pricey
Free-cash-flow yield (%) 2.92 58th percentile Good
US Stock Backtest in Python: Price-to-Book Ratio StrategyQuality Factor Investing: A US Quality Value Backtest
Quality Good FCF margin, TTM is Good, but ROE, TTM is Average.
ROE, TTM (%) 3.34 49th percentile Average
Operating margin, TTM (%) 13.04 61th percentile Good
FCF margin, TTM (%) 17.89 73th percentile Good
Quality Factor Investing: A US Quality Value Backtest
Growth Neutral All 2 indicators are Average.
Revenue growth, TTM YoY (%) 3.67 45th percentile Average
Diluted EPS growth, TTM YoY (%) -13.46 49th percentile Average
Momentum Strong All 2 indicators are Top.
60-day return (%) 37.49 96th percentile Top
240-day return (%) 69.72 92th percentile Top
Momentum Trading Strategy: A 12-1 Momentum Backtest
Risk / liquidity Good 20-day dollar volume is Top; 60-day annualized volatility is Good.
20-day dollar volume 269,262,516 94th percentile Top
60-day annualized volatility (%) 37.55 43th percentile Good

Revvity, Inc. (RVTY) today

2 quant signals active · As of 2026-10-30

Win rate and excess are historical post-trigger stats vs the market. Click a signal for its full definition and samples; history does not predict future results.

FinLab Studio

From Revvity, Inc. to every stock like it

AI finds several complementary traits of Revvity, Inc. across different dimensions, combines them into a multifactor strategy, and backtests it against the market.

Screen stocks like Revvity, Inc.

Revvity, Inc. (RVTY) peers and tracking

Watchlist

This page refreshes daily after the close. Add Revvity, Inc. to your watchlist to track signal changes on your next visit.

Revvity, Inc. (RVTY) quant signal backtests

Signals active now

Each active condition is tested against this stock’s own history and benchmarked versus the S&P 500.

52-week adjusted-price high

Active

Adjusted close first reaches a 252-trading-day high; repeated hits within 20 days count once.

22 historical occurrences (since 2017-03-15)

Average forward return after 52-week adjusted-price high

20-day: Win 63.6%, Sample 22, Median +2.11%, Excess -0.65%, Beat mkt rate 54.5%

60-day: Win 57.1%, Sample 21, Median +3.68%, Excess -1.99%, Beat mkt rate 42.9%

120-day: Win 71.4%, Sample 21, Median +2.42%, Excess -2.12%, Beat mkt rate 42.9%

120 days after: historical avg +4.39%

20-day +1.02%
60-day +1.32%
120-day +4.39%
20-day
60-day
120-day
Win
63.6%
57.1%
71.4%
Sample
22
21
21
Median
+2.11%
+3.68%
+2.42%
Excess
-0.65%
-1.99%
-2.12%
Beat mkt rate
54.5%
42.9%
42.9%

Over 21 occurrences, 120-day forward avg gained 4.39%, lagged the market by 2.12 pts; win rate 71.4%.

Top-quintile 6-month momentum

Active · now 96.43%

The stock ranks in the top 20% of the liquid US common-stock universe by 126-day adjusted return.

14 historical occurrences (since 2017-05-17)

Average forward return after Top-quintile 6-month momentum

20-day: Win 71.4%, Sample 14, Median +2.37%, Excess +1.91%, Beat mkt rate 57.1%

60-day: Win 69.2%, Sample 13, Median +3.87%, Excess -0.84%, Beat mkt rate 46.2%

120-day: Win 53.8%, Sample 13, Median +4.17%, Excess -3.53%, Beat mkt rate 46.2%

120 days after: historical avg +3.7%

20-day +3.57%
60-day +3.7%
120-day +3.7%
20-day
60-day
120-day
Win
71.4%
69.2%
53.8%
Sample
14
13
13
Median
+2.37%
+3.87%
+4.17%
Excess
+1.91%
-0.84%
-3.53%
Beat mkt rate
57.1%
46.2%
46.2%

Over 13 occurrences, 120-day forward avg gained 3.7%, lagged the market by 3.53 pts; win rate 53.8%.

Valuation regime and forward returns

Daily TTM P/E is converted into an expanding own-history percentile, then grouped into five valuation regimes. Forward returns use adjusted prices over the next 240 trading days.

PE percentile bandSample days240-day avg returnMedianWin rateAvg excess (vs index)
0-20 702+3.8% +0.3% 50.4% -9.2%
20-40 249-11.7% -19.9% 14.9% -23.9%
40-60 223+29.5% +32.6% 85.2% +4.4%
60-80 107-6.1% -13.3% 11.2% -21.4%
80-100 You are here127-19.7% -20.8% 0% -32.7%

Quarterly EPS is aligned by SEC filing date before it is forward-filled to daily prices. The expanding percentile uses only information available up to each day.

Current TTM P/E is about 75.31, placing it in the 97.8 own-history percentile, inside the 80-100 bucket.

More history: Valuation × momentum analogs, Market-wide momentum baseline, Signals not active now

Valuation × momentum analogs

Each historical day is grouped by own-history P/E tercile and 60-day momentum direction, then tested for the next 120-trading-day adjusted return.

Valuation
Momentum
Cheap (own-history bottom third)
Middle
Expensive (own-history top third)
60-day momentum up
+1.9%
Win rate 51.1% Excess -5.2%
421d
+17.3%
Win rate 80.8% Excess +3.8%
104d
Now
-2.3%
Win rate 48.6% Excess -9%
210d
60-day momentum down
+0.9%
Win rate 36.5% Excess -5.4%
521d
+18.2%
Win rate 66.7% Excess +6.1%
189d
-8%
Win rate 26.5% Excess -12.8%
83d

Currently in “Expensive (own-history top third) × 60-day momentum up”: across 210 historical days, 120-day forward avg declined 2.3%, win rate 48.6%, lagged the market by 9%.

Days = trading days in this bucket; returns use adjusted prices, ex-costs. 60-day momentum: direction of this stock's price over the past 60 trading days.

Market-wide momentum baseline

Across 99,493 liquid US common-stock samples, top-quintile 6-month momentum was followed by an average 60-trading-day return of +6.42%, a 58.4% positive-return rate, and +3.08 percentage points of average excess return versus the S&P 500.

Baseline: weekly samples since 2016 where a liquid US common stock ranked in the top quintile by 126-trading-day momentum. Forward return is 60 trading days; excess return is versus S&P 500 (^GSPC).

Signals not active now

Inactive signals still show the stock-specific historical forward-return distribution for context.

Filed revenue acceleration

Pending

TTM revenue growth is at least 10% and improved versus the prior filed quarter; event date is the SEC filing date.

7 times historically; 60-day forward avg +10.4%, win rate 71.4%, beating the market by +5.99 pts on average.

EPS surprise beat

Pending

Reported EPS beat consensus estimate by at least 5%; event date is the earnings-surprise timestamp.

6 times historically; 60-day forward avg +3.78%, win rate 33.3%, beating the market by -1.85 pts on average.

Method and limits

  • Returns use us_price:adj_close, adjusted for splits and dividends where available.
  • Excess returns use world_index:^GSPC as the S&P 500 benchmark proxy.
  • Quarterly fundamentals are aligned to SEC filing dates before daily valuation studies.
  • The promoted universe starts from active NYSE/NASDAQ common stocks, then applies price and dollar-volume gates.
  • Snapshot-only tables such as analyst consensus, DCF, us_ratios, and us_key_metrics are intentionally excluded from historical evidence.
  • Overlapping event windows are descriptive distributions, not independent samples.

This page is for historical data analysis and education only. It is not investment advice. Backtests and historical return distributions do not predict future performance; evaluate risk independently before trading.